NCT00224978View on ClinicalTrials.gov

Chloroquine for Treatment of Glioblastoma Multiforme

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2005

Study Completion Date

August 31, 2005

Conditions
Glioblastoma Multiforme
Interventions
DRUG

Chloroquine

Trial Locations (1)

14269

National Institute of Neurology and Neurosurgery, Mexico City

All Listed Sponsors
lead

National Institute of Neurology and Neurosurgery, Mexico

OTHER

NCT00224978 - Chloroquine for Treatment of Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter